CN115993415A - Novel method for detecting content of polymer in cefcapene pivoxil hydrochloride - Google Patents

Novel method for detecting content of polymer in cefcapene pivoxil hydrochloride Download PDF

Info

Publication number
CN115993415A
CN115993415A CN202310067507.8A CN202310067507A CN115993415A CN 115993415 A CN115993415 A CN 115993415A CN 202310067507 A CN202310067507 A CN 202310067507A CN 115993415 A CN115993415 A CN 115993415A
Authority
CN
China
Prior art keywords
polymer
cefcapene pivoxil
pivoxil hydrochloride
solution
mobile phase
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN202310067507.8A
Other languages
Chinese (zh)
Inventor
娄良
张和平
郭然
楼秋霞
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Zhongshan Bailing Biotechnology Co ltd
Original Assignee
Zhongshan Bailing Biotechnology Co ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zhongshan Bailing Biotechnology Co ltd filed Critical Zhongshan Bailing Biotechnology Co ltd
Priority to CN202310067507.8A priority Critical patent/CN115993415A/en
Publication of CN115993415A publication Critical patent/CN115993415A/en
Pending legal-status Critical Current

Links

Images

Classifications

    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Investigating Or Analysing Biological Materials (AREA)

Abstract

The invention belongs to the technical field of medical analysis, and particularly discloses a novel method for detecting the content of a polymer in cefcapene pivoxil hydrochloride. The method mainly adopts a high performance molecular exclusion chromatography (HPSEC) method to measure the size of the polymer in the cefcapene pivoxil hydrochloride by using an ultraviolet detector, and the chromatographic conditions are as follows: chromatographic column: a BioCoreEC-120,7.8X 300mm,5 μm or equivalent performance chromatographic column; mobile phase: a mixed solution of the mobile phase A and the mobile phase B according to the volume ratio of 95:5; wherein the mobile phase A is a mixed solution of 0.05mol/L disodium hydrogen phosphate aqueous solution and 0.05mol/L sodium dihydrogen phosphate aqueous solution according to a volume ratio of 1:1; the mobile phase B is acetonitrile; elution mode: isocratic elution; flow rate: 0.7-0.9 ml/min; column temperature: 25-35 ℃; detection wavelength: 254nm; sample injection amount: 10ul.

Description

Novel method for detecting content of polymer in cefcapene pivoxil hydrochloride
Technical Field
The invention relates to the technical field of medical analysis, in particular to a novel method for detecting the content of a polymer in cefcapene pivoxil hydrochloride.
Background
Cefcapene pivoxil hydrochloride is a fourth-generation orally-taken cephalosporin antibiotic, belongs to beta-lactam antibiotics, and is suitable for infection caused by streptococcus, staphylococcus, gonococcus and the like. Research shows that the immediate allergic reaction caused by the beta-lactam antibiotics is not caused by the medicine itself, and is related to the high molecular polymer existing in the medicine. The various polymeric impurities in the beta-lactam antibiotics have similar biological characteristics (such as hypersensitivity) although the structures are different, so that the polymers with different structures are not required to be controlled one by one in quality control, and only the total amount of the polymers is required to be controlled. The high molecular polymer in cephalosporin antibiotics refers to the total term of impurities with molecular weight larger than that of the drug, and the molecular weight is generally 1000-5000Da, and the molecular weight can reach about 15000Da respectively.
Because the high molecular polymer has high heterogeneity and uncertainty, a reference substance with fixed content cannot be prepared, no related cefcapene pivoxil hydrochloride polymer detection method exists in the prior patent and literature, and related determination methods are not recorded in foreign pharmacopoeias such as USP and EP. The method for measuring the high polymer in the beta-lactam antibacterial drug by using the self-contrast external standard method is carried out in the 2020 edition of Chinese pharmacopoeia, and adopts a gel chromatography method which takes glucose gel Sephadex G-10 as a chromatographic column. The high molecular polymer in the drug is detected by using the drug self-reference substance to replace the high molecular polymer reference substance through switching of two mobile phases, which is a common technology at present and is used for detecting the polymer in the cephalosporin antibiotics. However, the method has the disadvantages of low column efficiency (about 1000), tailing peak shape, long analysis time, poor separation effect of high polymer impurities (all high polymer is one peak, and the separation effect of the peak and a main peak baseline is poor), very low detection amount of the high polymer, and the like of the gel chromatographic column. Therefore, the production process of cefcapene pivoxil hydrochloride bulk drug and the quality control of finished products are very inconvenient, and the content of the polymer in the cefcapene pivoxil hydrochloride cannot be rapidly and accurately quantified.
Therefore, the detection method for rapidly and effectively determining the polymer content in the cefcapene pivoxil hydrochloride, which is simple to operate and high in sensitivity, is very important.
Disclosure of Invention
The invention aims at: the invention overcomes the defects in the prior gel chromatography technology, provides a detection method for rapidly and effectively determining the content of the polymer in cefcapene pivoxil hydrochloride, and is different from the traditional gel chromatography method applied to the detection of the polymer in antibiotics.
The invention adopts a High Performance Size Exclusion Chromatography (HPSEC) method to measure the polymer content in the cefuroxime axetil hydrochloride. By differentiating the sizes of the component molecules, the high-efficiency molecular exclusion chromatography can permeate into the macropores of the gel, while the small component molecules can permeate into the macropores and the micropores of the macropores, even enter deeply, and are not easy to elute. Therefore, the large component molecules have short residence time in the chromatographic column and are eluted quickly, and the large component molecules and the small component molecules are separated according to the molecular size in the size exclusion chromatographic system to complete the elution process.
In order to achieve the above purpose, the present invention adopts the following technical scheme:
a novel method for detecting the content of a biliary polymer in cefcapene pivoxil hydrochloride adopts a high-performance molecular exclusion chromatography (HPSEC) method to detect the size of the polymer in the cefcapene pivoxil hydrochloride by using an ultraviolet detector, and the chromatographic conditions are as follows:
chromatographic column: a BioCoreEC-120,7.8X 300mm,5 μm or equivalent performance chromatographic column;
mobile phase: a mixed solution of the mobile phase A and the mobile phase B according to the volume ratio of 95:5;
wherein the mobile phase A is a mixed solution of 0.05mol/L disodium hydrogen phosphate aqueous solution and 0.05mol/L sodium dihydrogen phosphate aqueous solution according to a volume ratio of 1:1; the mobile phase B is acetonitrile;
elution mode: isocratic elution;
flow rate: 0.7-0.9 ml/min;
column temperature: 25-35 ℃;
detection wavelength: 254nm;
sample injection amount: 10ul.
In the invention, the ultraviolet detector is a differential refraction detector, and the temperature of the detector is 35 ℃.
In the invention, the column temperature of the chromatographic column is preferably 30 ℃; the flow rate is preferably 0.8ml/min.
In the invention, the novel method for detecting the content of the liner polymer in the cefcapene pivoxil hydrochloride comprises the following steps:
a. preparing a blank solution: using a diluent as a blank solution;
b. preparing a sample solution: taking a cefcapene pivoxil hydrochloride sample, and dissolving the cefcapene pivoxil hydrochloride sample into a sample solution (prepared by clinical use) with the concentration of 0.1mg/ml by using a diluent;
c. preparing self-control solution: b, precisely measuring 1ml of the sample solution in the step b, placing the sample solution in a 100ml measuring flask, adding a diluent to dilute to a scale, and shaking uniformly to serve as a self control solution;
d. and respectively taking 10ul of blank solution, self-control solution and sample solution, respectively injecting into a liquid chromatograph, respectively recording the peak area of cefcapene pivoxil hydrochloride in the chromatogram, and calculating the content of the polymer in the cefcapene pivoxil hydrochloride sample according to the peak area self-control external standard method.
The diluent is a mixed solution of a mobile phase and methanol according to the volume of 1:1.
In summary, the beneficial effects of the invention are as follows:
the method can rapidly and accurately determine the content of the polymer in the cefcapene pivoxil hydrochloride. Compared with the existing gel chromatography method using glucose gel Sephadex G-10 as chromatographic column. The method of the invention uses high-efficiency molecular exclusion chromatography and cooperates with SEC chromatographic column, and the method has strong specificity, high accuracy and high sensitivity. The ultraviolet detector (UV) with higher cost performance is selected, and the reversed-phase ultra-high performance liquid chromatography is applied, so that the method has the advantages of strong reliability and low detection cost, and is suitable for quality inspection of intermediate products and finished products in cefcapene pivoxil hydrochloride production.
Drawings
FIG. 1 is a chromatogram of a white solvent S1 in the example;
FIG. 2 is a chromatogram of cefcapene pivoxil hydrochloride sample solution S2 in the example;
FIG. 3 is a chromatogram of cefcapene pivoxil hydrochloride control solution S3 in the example;
FIG. 4 is a chromatogram of a cefcapene pivoxil hydrochloride control solution in comparative example 1;
FIG. 5 is a chromatogram of the cefcapene pivoxil hydrochloride control solution of comparative example 2.
Detailed Description
The invention is further illustrated, but not limited, by the following examples.
Examples
The test sample of cefcapene pivoxil hydrochloride selected in the embodiment is cefcapene pivoxil hydrochloride self-made by Zhongshan lark biotechnology Co., ltd.
The chromatographic conditions used in this example are shown in table 1:
TABLE 1 chromatographic System conditions
Figure BDA0004073611730000051
The method for measuring the content of the cefcapene pivoxil hydrochloride polymer comprises the following steps:
a. preparing a blank solution: as blank solution S1, a mobile phase, alcohol=1:1 diluent was used;
b. preparing a sample solution: taking a cefcapene pivoxil hydrochloride sample, and dissolving the cefcapene pivoxil hydrochloride sample into a sample solution S2 (prepared by clinical use) with the concentration of 0.1mg/ml by using a diluent;
c. preparing self-control solution: b, precisely measuring 1ml of the sample solution S2 in the step b, placing the sample solution into a 100ml measuring flask, adding a diluent to dilute to a scale, and shaking uniformly to serve as self-control solution S3;
the diluent is a mixed solution of a mobile phase and methanol according to the volume ratio of 1:1.
d. And respectively taking 10ul of blank solution S1, self control solution S3 and sample solution S2, respectively, injecting into a liquid chromatograph, recording the peak area of cefcapene pivoxil hydrochloride in a cefcapene pivoxil hydrochloride control solution chromatogram (shown in figure 3) and the peak area of a polymer in the cefcapene pivoxil hydrochloride sample solution chromatogram (shown in figure 2), and calculating the content C of the polymer according to a peak area self-control external standard method.
The calculation formula is as follows:
Figure BDA0004073611730000061
wherein: as is the peak area of the main component in the self-control solution;
ai is the peak area of the polymer in the sample solution
The total content of the polymer in the cefcapene pivoxil hydrochloride test sample is 1.0% according to the formula.
Methodology investigation
To further verify the feasibility of the method, the following methodological investigation was performed:
1. specificity test
The cefcapene pivoxil hydrochloride sample is precisely weighed, a proper amount of the cefcapene pivoxil hydrochloride sample is prepared into 0.05mg/ml of test solution by using a diluent, 10ul of sample is taken, and the separation degree and theoretical plate number of the chromatogram polymer are recorded, and the result is shown in Table 2.
TABLE 2 results of specificity experiments
Figure BDA0004073611730000062
The results show that: the number of theoretical pedals of each peak is not less than 2000, and the separation degree is not less than 1.5.
2. Limit of detection and limit of quantification test
Precisely weighing cefcapene pivoxil hydrochloride reference substance, preparing into a certain concentration with diluent, respectively sucking 10ul solution, injecting into a liquid chromatograph, and recording a chromatogram. The results are shown in Table 3, with the concentration at a signal to noise ratio of about 3:1 as the limit of detection and the concentration at a signal to noise ratio of about 10:1 as the limit of quantification.
TABLE 3 detection limit and quantitative limit test results
Figure BDA0004073611730000071
The results show that: the detection limit of the polymer in the cefcapene pivoxil hydrochloride is 0.000050mg/ml, and the quantitative limit is 0.00010mg/ml.
3. Linearity test
Precisely weighing cefcapene pivoxil hydrochloride reference substance, and respectively preparing into linear solutions of 0.00010mg/ml, 0.00030mg/ml, 0.00040mg/ml, 0.00050mg/ml, 0.00060mg/ml and 0.00070mg/ml by using a diluent. 10ul of the solution was taken and poured into a liquid chromatograph, and the chromatogram was recorded, and the peak areas of the concentrations are shown in Table 4.
TABLE 4 Linear experiment results
Figure BDA0004073611730000072
Figure BDA0004073611730000081
Linear regression was performed on peak area with concentration to obtain a linear equation correlation coefficient r=0.9997.
The results show that: cefcapene pivoxil hydrochloride has good linearity within the concentration range of 0.00010mg/ml to 0.00070 mg/ml.
4. Precision test
Precisely weighing a proper amount of cefcapene pivoxil hydrochloride reference substance, respectively dissolving and diluting to 0.0005mg/ml with a diluent, respectively taking 10ul solution, injecting into a liquid chromatograph, and continuously sampling for 6 times. The chromatogram was recorded and the results are shown in table 5.
TABLE 5 repeatability test results
Figure BDA0004073611730000082
Figure BDA0004073611730000091
The above test was repeated by different personnel at different times and the results are shown in Table 6.
TABLE 6 results of intermediate precision test
Figure BDA0004073611730000092
The results show that: the method has good precision.
5. Solution stability test
Accurately weighing cefcapene pivoxil hydrochloride reference substance, dissolving and diluting to 0.0005mg/ml with diluent, standing at normal temperature for 0h, 4h and 8h respectively, sampling, and recording peak area change of main component, and the result is shown in Table 7.
TABLE 7 results of solution stability test
Figure BDA0004073611730000093
The results show that: the cefcapene pivoxil hydrochloride solution is unstable at normal temperature and needs to be prepared newly.
6. Method durability test
Precisely weighing a proper amount of biliverdin reference substance, dissolving and diluting to 0.005mg/ml with diluent, performing small-scale modification on the flow rate in chromatographic conditions and chromatographic column temperature conditions, examining the influence on the retention time, the separation degree and the theoretical plate number of the main component, and examining the results shown in Table 8.
Table 8 method durability test results
Figure BDA0004073611730000101
Figure BDA0004073611730000111
/>
The theoretical plate numbers of the polymer peak and the main component peak under each condition are larger than 2000, and the separation degree between the adjacent two peaks is larger than 1.5, which shows that the measurement conditions meet the durability requirement when the measurement conditions have small variation.
Comparative example
In this comparative example, two comparative examples 1 and 2, which are different from the chromatographic conditions in the examples, were set.
The chromatographic conditions used in comparative example 1 are shown in table 9.
TABLE 9 chromatographic System conditions
Figure BDA0004073611730000112
The chromatographic conditions used in comparative example 2 are shown in table 10.
TABLE 10 chromatographic system conditions
Figure BDA0004073611730000121
The control solutions themselves were prepared as described in the examples, and the peak areas of cefcapene pivoxil hydrochloride in the chromatograms (shown in fig. 4 and 5) of the cefcapene pivoxil hydrochloride control solutions were recorded according to the chromatographic conditions in table 9 of comparative example 1 and table 10 of comparative example 2, respectively.
According to the figure 3 in the embodiment, the peak shape of each peak of the comparison is good, the separation degree meets the requirement, and the analysis time is proper; as can be seen from FIG. 4, in comparative example 1, although the analysis time was short, the separation of each peak was poor, and the degree of separation was unsatisfactory; it can be seen from fig. 5 that the analysis time was long and the peak shape was also poor in comparative example 2.

Claims (6)

1. A novel method for detecting the content of a biliary polymer in cefcapene pivoxil hydrochloride is characterized in that an ultraviolet detector is applied to the determination of the size of the polymer in the cefcapene pivoxil hydrochloride by adopting a high-efficiency molecular exclusion chromatography, and the chromatographic conditions are as follows:
chromatographic column: a BioCoreEC-120,7.8X 300mm,5 μm or equivalent performance chromatographic column;
mobile phase: a mixed solution of the mobile phase A and the mobile phase B according to the volume ratio of 95:5;
wherein the mobile phase A is a mixed solution of 0.05mol/L disodium hydrogen phosphate aqueous solution and 0.05mol/L sodium dihydrogen phosphate aqueous solution according to a volume ratio of 1:1; the mobile phase B is acetonitrile;
elution mode: isocratic elution;
flow rate: 0.7-0.9 ml/min;
column temperature: 25-35 ℃;
detection wavelength: 254nm;
sample injection amount: 10ul.
2. The method for detecting the content of the liner polymer in the cefcapene pivoxil hydrochloride according to claim 1, wherein the ultraviolet detector is a differential refraction detector, and the temperature of the detector is 35 ℃.
3. The novel method for detecting the content of the biliary polymer in cefcapene pivoxil hydrochloride according to claim 1, wherein the column temperature of the chromatographic column is 30 ℃.
4. The novel method for detecting the content of the biliary polymer in cefcapene pivoxil hydrochloride according to claim 1, wherein the flow rate is 0.8ml/min.
5. The novel method for detecting the content of the biliary polymer in the cefcapene pivoxil hydrochloride according to claim 1, which is characterized by comprising the following steps:
a. preparing a blank solution: using a diluent as a blank solution;
b. preparing a sample solution: taking a cefcapene pivoxil hydrochloride sample, and dissolving the cefcapene pivoxil hydrochloride sample into a sample solution with the concentration of 0.1mg/ml by using a diluent;
c. preparing self-control solution: precisely measuring 1ml of the sample solution in the step b, placing the sample solution in a 100ml measuring flask, adding a diluent to dilute to a scale, and shaking uniformly to serve as a self control solution;
d. and respectively taking 10ul of blank solution, self-control solution and sample solution, respectively injecting into a liquid chromatograph, respectively recording the peak area of cefcapene pivoxil hydrochloride in the chromatogram, and calculating the content of the polymer in the cefcapene pivoxil hydrochloride sample according to the peak area self-control external standard method.
6. The method for detecting the content of the biliary polymer in cefcapene pivoxil hydrochloride according to claim 5, wherein the diluent is a mixed solution of a mobile phase and methanol in a volume ratio of 1:1.
CN202310067507.8A 2023-01-13 2023-01-13 Novel method for detecting content of polymer in cefcapene pivoxil hydrochloride Pending CN115993415A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN202310067507.8A CN115993415A (en) 2023-01-13 2023-01-13 Novel method for detecting content of polymer in cefcapene pivoxil hydrochloride

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN202310067507.8A CN115993415A (en) 2023-01-13 2023-01-13 Novel method for detecting content of polymer in cefcapene pivoxil hydrochloride

Publications (1)

Publication Number Publication Date
CN115993415A true CN115993415A (en) 2023-04-21

Family

ID=85991771

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202310067507.8A Pending CN115993415A (en) 2023-01-13 2023-01-13 Novel method for detecting content of polymer in cefcapene pivoxil hydrochloride

Country Status (1)

Country Link
CN (1) CN115993415A (en)

Similar Documents

Publication Publication Date Title
CN102798678B (en) Detection method and content determining method of sodium calcium edetate in pantoprazole sodium for injecting
CN107884498A (en) Liquid phase chromatography analytical method that is a kind of while determining procaine, penicillin and content of streptomycin
CN115097023A (en) High performance liquid chromatography detection method for zolmitamine related substances
CN109387587B (en) Detection method of L-2-amino-5-guanidino valeric acid enantiomer
CN109374781B (en) Method for detecting related substances in mezlocillin sodium and sulbactam sodium for injection
WO2022116971A1 (en) Method for detecting content of active ingredients of compound sophorae flavescentis radix injection and fingerprint spectrum thereof
CN104458984A (en) Method for determining polymer in cephalosporins drug
Tozo et al. Determination of lomefloxacin in tablet preparations by liquid chromatography
CN102269749B (en) Method for detecting adenosine content in hericium erinaceus tablet
CN109946398B (en) Method for detecting dalbavancin and impurities thereof
CN101658550A (en) Method for measuring content of selfheal oral liquid
CN115993415A (en) Novel method for detecting content of polymer in cefcapene pivoxil hydrochloride
CN102841169B (en) Method for measuring calcium levofolinate-related substances by using high performance liquid chromatography gradient method
CN113588837B (en) Detection method of moxifloxacin hydrochloride related substance
CN112684031B (en) HPLC (high Performance liquid chromatography) determination method for content of povidone K30
CN110208397B (en) High performance liquid chromatography for simultaneously determining contents of two main drugs in oxytetracycline and flunixin injection
CN109613163B (en) Detection method for pimavanserin tartrate and impurities thereof
CN111679004A (en) Quality control method of probucol
CN107884496B (en) Method for determining content of succinic acid in trelagliptin succinate
CN112305100B (en) Method for detecting content of genotoxic impurity benzyl bromide in medicine
CN110824070B (en) Method for detecting contents of sorbitol and methionine in ginkgo biloba extract preparation
CN112611819B (en) Method for measuring related substances in benfotiamine raw material and preparation thereof
CN108107120B (en) Method for measuring intermediate product 6, 6-dibromo penicillanic acid by adopting high performance liquid chromatography
CN110907548B (en) Method for detecting biapenem and/or related substances
CN114839300B (en) Method for measuring 6 chemical components in fingered citron by adopting one-measurement-multiple-evaluation method

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination